Neoleish (canine leishmaniasis vaccine (recombinant DNA plasmid)) is used for the active immunization of Leishmania-negative dogs from 6 months of age. Given to reduce the risk of developing an active infection and/or clinical disease following exposure to the parasite Leishmania infantum.